セーフティランセットの市場規模、シェア、成長分析、製品タイプ別、用途別、エンドユーザー別、地域別-2025～2032年産業予測

セーフティランセット市場規模は2023年に17億4,000万米ドルで、予測期間（2025～2032年）のCAGRは9.5%で、2024年の19億1,000万米ドルから2032年には39億4,000万米ドルに成長する展望です。

セーフティランセット市場は、糖尿病や感染症の罹患率の上昇に後押しされ、大きな成長を遂げています。血糖値モニタリングや診断検査の重要なツールとして、ランセットは医療に欠かせないものとなりつつあります。市場は、より安全で利便性の高い、使い勝手の良い使い捨てランセットへの需要がますます高まっています。インドや中国などの新興市場は、医療施設の増加や健康意識の高まりにより、拡大の機が熟しています。しかし、医療従事者間の感染症伝播のリスクとなる針刺し損傷への懸念など、市場は課題に直面しています。さらに、再使用されたランセットからの感染リスクは、医療診療におけるより安全な選択として、使い捨てオプションへのシフトを強調しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主要市場の考察

• 重要成功要因
• 競合の程度
• 主要投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

セーフティランセット市場規模：製品タイプ別&CAGR（2025～2032年）

• 市場概要
• プッシュボタンセーフティランセット
• 圧力活性化セーフティランセット
• サイドボタンセーフティランセット

セーフティランセット市場規模：用途別&CAGR（2025～2032年）

• 市場概要
• 血糖値検査
• ヘモグロビン検査
• コレステロール検査
• 凝固検査

セーフティランセット市場規模：エンドユーザー別&CAGR（2025～2032年）

• 市場概要
• 病院とクリニック
• 診断センターと病理学ラボ
• ホーム診断
• その他

セーフティランセット市場規模&CAGR（2025～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主要市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

    主要企業プロファイル

    • Cardinal Health（米国）
    • Greiner Bio-One International GmbH（オーストリア）
    • Sarstedt AG & Co. KG（ドイツ）
    • Nipro Corporation（日本）
    • Improve Medical Technology Co. Ltd.（中国）
    • Simple Diagnostics（米国）
    • Ypsomed AG（スイス）
    • Owen Mumford Ltd.（英国）
    • Arkray Inc.（日本）
    • Perrigo Company plc（アイルランド）
    • Smiths Medical（米国）
    • Medline Industries, Inc.（米国）
    • Omron Healthcare, Inc.（日本）
    • F. Hoffmann-La Roche AG（スイス）
    • Trinity BIoTech（アイルランド）
    • Microdot Healthcare（英国）
    • MED TRUST Holding Co.（オーストリア）
    • Nemaura Medical Inc.（英国）

結論と提言

Safety Lancet Market size was valued at USD 1.74 billion in 2023 and is poised to grow from USD 1.91 billion in 2024 to USD 3.94 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The safety lancet market is experiencing significant growth, fueled by the rising incidence of diabetes and infectious diseases. As critical tools for blood glucose monitoring and diagnostic testing, lancets are becoming essential in healthcare. The market is increasingly driven by the demand for user-friendly, single-use lancets that offer greater safety and convenience. Emerging markets such as India and China are ripe for expansion, thanks to an increasing number of healthcare facilities and heightened health awareness. However, the market faces challenges, including concerns over needlestick injuries that risk infectious disease transmission among healthcare workers. Furthermore, the risk of infection from reused lancets underscores the shift toward single-use options as a safer choice in healthcare practices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Safety Lancet market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Safety Lancet Market Segments Analysis

Global Safety Lancet Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Push Button Safety Lancet, Pressure Activated Safety Lancet and Side Button Safety Lancet. Based on Application, the market is segmented into Blood Glucose Testing, Haemoglobin Testing, Cholesterol Testing and Coagulation Testing. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Safety Lancet Market

The safety lancet market is experiencing significant growth driven by the rising prevalence of diabetes, a health concern projected to double over the next quarter-century. This increase is largely due to the escalating rates of both type 1 and type 2 diabetes, which place considerable strain on global healthcare systems. Factors contributing to the rise in diabetes include lifestyle choices such as obesity, sedentary habits, smoking, and urbanization. The aging population also plays a crucial role, as older individuals are more susceptible to diabetes. Consequently, the growing need for effective diabetes management solutions will likely lead to a higher adoption of safety lancets in the coming years.

Restraints in the Safety Lancet Market

The safety lancet market encounters significant challenges to its growth primarily due to the limited awareness surrounding homecare lancets, especially in developing countries worldwide. This lack of knowledge presents a considerable barrier, as it restricts the adoption of these essential devices by individuals who could greatly benefit from their use for various diagnostic and monitoring applications. As potential users remain uninformed about the advantages and functionalities of homecare lancets, the market struggles to reach its full potential, hindering efforts to improve health outcomes through enhanced accessibility to necessary medical tools. Addressing this awareness gap is crucial for market expansion.

Market Trends of the Safety Lancet Market

The safety lancet market is witnessing robust growth, propelled by ongoing technological advancements and an increasing emphasis on patient safety. Innovations in design, such as retractable lancets that automatically shield the needle post-use, are becoming pivotal in minimizing needlestick injuries and enhancing user confidence. This trend is further supported by rising awareness around safe blood sampling practices and stringent regulatory standards mandating the use of safer medical devices. Additionally, the growing prevalence of diabetes and other chronic conditions necessitating regular blood glucose monitoring is driving demand. Collectively, these factors are forging a dynamic landscape for the safety lancet market through 2023 and beyond.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Safety Lancet Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Push Button Safety Lancet
• Pressure Activated Safety Lancet
• Side Button Safety Lancet

Global Safety Lancet Market Size by Application & CAGR (2025-2032)

• Market Overview
• Blood Glucose Testing
• Haemoglobin Testing
• Cholesterol Testing
• Coagulation Testing

Global Safety Lancet Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Centers and Pathology Laboratories
• Home Diagnostics
• Others

Global Safety Lancet Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Cardinal Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Greiner Bio-One International GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sarstedt AG & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Improve Medical Technology Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Simple Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microdot Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MED TRUST Holding Co. (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemaura Medical Inc. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations